Catalyst Wire Dossier Catalyst Wire Dossier

Autologous Platelet-Rich Plasma (PRP) intra-ovarian infusion

platelet-rich plasma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous Platelet-Rich Plasma (PRP) intra-ovarian infusion, covering 2024-12-27 to 2024-12-27. Get the full timeline:

Most recent: Clinical Trial Update: Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women [Phase 2, Phase 3]

See pricing